Small Talk: Ambulatory Care COVID-19 Antivirals (Paxlovid, Lagevrio): Overview for Healthcare Professionals

A presentation highlighting the two available oral treatment options for mild to moderate COVID-19 in the ambulatory care setting.

Objectives:

• Review the IDSA guidelines for treatment of mild to moderate COVID-19 infection in the ambulatory care setting
• Explore the difference between FDA approval and Emergency Use Authorization
• Describe the dosing, side effects and drug interactions associated with Paxlovid and Lagevrio
• Summarize the published COVID-19 efficacy data for Paxlovid and Lagevrio